Skip to main content

Analysis of Pathological Activities of CCN Proteins in Fibrotic Diseases: Liver Fibrosis

  • Protocol
  • First Online:
CCN Proteins

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1489))

Abstract

Hepatic fibrosis is a complex pathology arising from chronic injury. Pathological features are dominated by the excessive production of extracellular matrix proteins, particularly collagens which are deposited as insoluble scar material that can compromise tissue function. Fibrosis in the liver can often be assessed by staining for collagen in tissue sections and this is an approach that is widely used for grading of fibrosis in human biopsies. However, the recognition of the molecular components that drive fibrosis, including CCN proteins, and the involvement of hepatic stellate cells (HSC) as the principal collagen-producing cells in fibrosing liver, has resulted in a wide variety of molecular and cellular approaches to study the pathogenesis of fibrosis both in vivo and in vitro.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Friedman SL (2008) Hepatic fibrosis—overview. Toxicology 254:120–129

    Article  CAS  PubMed  Google Scholar 

  2. Friedman SL (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275:2247–2250

    Article  CAS  PubMed  Google Scholar 

  3. Liu X, Xu J, Brenner DA, Kisseleva T (2013) Reversibility of liver fibrosis and inactivation of fibrogenic myofibroblasts. Curr Pathobiol Rep 1:209–214

    Article  PubMed  PubMed Central  Google Scholar 

  4. Trautwein C, Friedman SL, Schuppan D, Pinzani M (2015) Hepatic fibrosis: concept to treatment. J Hepatol 62:S15–S24

    Article  CAS  PubMed  Google Scholar 

  5. Huang G, Brigstock DR (2012) Regulation of hepatic stellate cells by connective tissue growth factor. Front Biosci 17:2495–2507

    Article  Google Scholar 

  6. Brigstock DR (2009) Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): from pharmacological inhibition in vitro to targeted siRNA therapy in vivo. J Cell Commun Signal 3:5–18

    Article  PubMed  PubMed Central  Google Scholar 

  7. Chen L, Charrier A, Zhou Y, Chen R, Yu B, Agarwal K, Tsukamoto H, Lee LJ, Paulaitis ME, Brigstock DR (2014) Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology 59:1118–1129

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Chen L, Chen R, Kemper S, Charrier A, Brigstock DR (2015) Suppression of fibrogenic signaling in hepatic stellate cells by Twist1-dependent microRNA-214 expression: role of exosomes in horizontal transfer of Twist1. Am J Physiol Gastrointest Liver Physiol 309:G491–G499

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Constandinou C, Henderson N, Iredale JP (2005) Modeling liver fibrosis in rodents. Methods Mol Med 117:237–250

    PubMed  Google Scholar 

  10. Tsukamoto H, Matsuoka M, French SW (1990) Experimental models of hepatic fibrosis: a review. Semin Liver Dis 10:56–65

    Article  CAS  PubMed  Google Scholar 

  11. Anstee QM, Goldin RD (2006) Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 87:1–16

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Chisari FV, Pinkert CA, Milich DR, Filippi P, McLachlan A, Palmiter RD, Brinster RL (1985) A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 230:1157–1160

    Article  CAS  PubMed  Google Scholar 

  13. Koteish A, Diehl AM (2001) Animal models of steatosis. Semin Liver Dis 21:89–104

    Article  CAS  PubMed  Google Scholar 

  14. Hillebrandt S, Goos C, Matern S, Lammert F (2002) Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15. Gastroenterology 123:2041–2051

    Article  CAS  PubMed  Google Scholar 

  15. Leask A, Chen S, Pala D, Brigstock DR (2008) Regulation of CCN2 mRNA expression and promoter activity in activated hepatic stellate cells. J Cell Commun Signal 2:49–56

    Article  PubMed  PubMed Central  Google Scholar 

  16. Chen L, Charrier AL, Leask A, French SW, Brigstock DR (2011) Ethanol-stimulated differentiated functions of human or mouse hepatic stellate cells are mediated by connective tissue growth factor. J Hepatol 55:399–406

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Work in the authors’ laboratory is supported by R01AA021276 and 1R211AA023626-01A1 awarded to D.R.B.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Li Chen Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media New York

About this protocol

Cite this protocol

Chen, L., Brigstock, D.R. (2017). Analysis of Pathological Activities of CCN Proteins in Fibrotic Diseases: Liver Fibrosis. In: Takigawa, M. (eds) CCN Proteins. Methods in Molecular Biology, vol 1489. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6430-7_37

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6430-7_37

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-6428-4

  • Online ISBN: 978-1-4939-6430-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics